LITTLE KNOWN FACTS ABOUT MBL77.

Not all patients with CLL call for therapy. Irrespective of all the latest innovations, the iwCLL continue to suggests watchful observation for individuals with asymptomatic disease.86 This recommendation is based on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and ritux